Coronavirus: Vaccination

Everyone from age 5 can be vaccinated. Boosters with an mRNA vaccine are recommended for everyone aged 16 and over.

COVID-19 vaccination infoline

+41 800 88 66 44, every day from 6am to 11pm

COVID-19 Vaccination Check

Use the COVID-19 Vaccination Check to find out whether and where you can get a COVID-19 vaccination or booster. According to the details you enter, you will be directed to the relevant point of contact in your canton, where you can register for your vaccination. Watch the video (in German, French or Italian) to find out just how easy the COVID-19 Vaccination Check is to use.

Visit the COVID-19 Vaccination Check

Where can I register for a vaccination?

Your canton is responsible for the vaccination. On your canton’s website you’ll find answers to the following questions: How is the vaccination organised? How can you register? There is a list of cantonal websites at

Or do the COVID-19 Vaccination Check. According to the details you enter, you will be directed to the relevant point of contact in your canton, where you can register for your vaccination.

Why should I get vaccinated?

Seven good reasons to get vaccinated:

  • You protect yourself from catching COVID-19 and getting very sick.
  • You get immunity the safe way.
  • You help reduce the number of cases.
  • You help combat the effects of the pandemic.
  • You prevent potential long-term debilitating effects of COVID-19 (long-term effects of COVID-19)
  • You help relieve pressure on the healthcare system.
  • You help us get our everyday freedoms back.

Who can get vaccinated?

Anyone from age 5 can be vaccinated. From January 2022, children aged from 5 to 11 have been able to be vaccinated with the Pfizer/BioNTech vaccine for children.

I have recovered from COVID. Should I get vaccinated?

The vaccination is also recommended if you have recovered from COVID. You are protected from renewed infection for a certain period of time, but it is not clear how long for. You are better protected against a renewed infection if you are vaccinated. We therefore recommend that you have the vaccination within three months of infection to give you long-term protection. From 4 weeks after a confirmed coronavirus infection, one dose of vaccine is sufficient. You do not have to have a second dose.

Was the infection more than three months ago? If so, you should get vaccinated as soon as possible. In this situation too, you only required one vaccine dose for full vaccination.

There are exceptions for people at especially high risk. For more information about this please consult your doctor.

You will find information on the booster vaccination in the Should I have a booster vaccination? section.

I am pregnant or trying for a baby. Can I get vaccinated?

We recommend the COVID-19 vaccination with an mRNA vaccine before or during pregnancy as pregnant women are much more likely to suffer severe symptoms than non-pregnant women of the same age. The risk of premature birth is also significantly increased if you catch coronavirus during pregnancy. Vaccination before or during pregnancy protects both you and your unborn child.

Are you trying for a baby? If so, you should get vaccinated as soon as possible.

Are you already pregnant and didn’t get vaccinated before you got pregnant? If so, we recommend the vaccination from 12 weeks of pregnancy (i.e. from the 2nd trimester). In principle, it is also possible to get vaccinated at an earlier stage of pregnancy.

If you’re pregnant or are trying for a baby and have questions on vaccination, talk to your doctor or midwife.

Can children and adolescents be vaccinated?

Vaccination of young people aged 12 and over

The vaccines produced by Pfizer/BioNTech and Moderna are approved for persons aged 12 and over.

Vaccination is recommended for all young people aged 12 and over. The vaccination protects against frequent mild and very rare severe cases of COVID-19. It also helps to avoid the negative consequences of protective measures (e.g. isolation/quarantine) and the consequences of frequent exposure (e.g. at school or in their leisure time).

The recommendation applies in particular to

  • adolescents with a chronic illness
  • adolescents who are close contacts (e.g. household members) of people at especially high risk, particularly of people with a weakened immune system
  • adolescents living in community institutions where there is a higher risk of infection and outbreaks of the disease.

Vaccination of children from 5 to 11

The Pfizer/BioNTech vaccine for children has been authorised in Switzerland for children from age 5 since 10 December 2021.

Vaccination is recommended for children from age 5 to 11 whose parents or legal guardians wish them to have it. It is advised to assess the risks and benefits in each individual case. You will find more information on this in the Fact sheet on the vaccination for children (PDF, 324 kB, 27.12.2021).

The recommendation applies particularly to:

  • Children with a chronic illness
  • Children who are close contacts (e.g. household members) of people at high risk, especially people with a weakened immune system.

The recommendation for children in the above-mentioned groups who have recovered from a confirmed coronavirus infection is only one dose of vaccine. No vaccination is currently recommended for any other children who have recovered from COVID-19.

This is a specially manufactured children’s vaccine. The dosage is lower than in the vaccine for people age 12 and over.

Who can receive the Janssen viral vector vaccine?

We recommend vaccination with an mRNA vaccine for everyone aged 12 and over. These vaccines offer optimal protection against COVID-19 and its potential effects.

Are you 18 or over? If so, you can receive the Janssen viral vector vaccine in the following cases:

  • If you are unable to receive an mRNA vaccine for medical reasons.
  • If you don’t want to be vaccinated with an mRNA vaccine.

If you’re pregnant or breastfeeding or if you have a weakened immune system, we still recommend vaccination with an mRNA vaccine.  

Should I have a booster vaccination?

A booster vaccination with an mRNA vaccine from Moderna or Pfizer/BioNTech is recommended from 4 months after the primary vaccination course (initial immunisation) for everyone aged 16 or over.

For optimal protection from a severe case of COVID-19 and hospitalisation, a booster is recommended for everyone aged 65 or over, in particular:

  • people aged 75 or over;
  • people aged 65 or over with chronic diseases that put them at the highest risk of getting a severe case of COVID-19;
  • residents and people being looked after in nursing homes, care homes and day care facilities for older adults.

In those aged under 65, the booster can increase protection from infection, mild disease and the consequences of catching COVID-19 (e.g. long COVID, missing work) and can help temporarily reduce circulation of the virus. The booster vaccination is therefore recommended for everyone aged between 16 and 64, in particular:

  • people at especially high risk aged under 65 with chronic diseases that put them at the highest risk of getting a severe case of COVID-19.
  • residents and people under 65 being looked after in nursing homes, care homes and day care facilities for older adults.
  • healthcare workers with direct patient contact and carers of people at especially high risk.

The booster is also recommended for pregnant women from the 2nd trimester and women who are breastfeeding.

Have you tested positive for coronavirus after full vaccination? You can find out whether you need a booster in the FAQ Do I need a booster if I tested positive for coronavirus after receiving my initial vaccination?.  

Where possible, the same vaccine should be administered for the booster as for the first two vaccinations.


  • People under 30 should preferably receive the Pfizer/BioNTech vaccine for their booster. 
  • People who have been vaccinated with the Janssen viral vector vaccine are recommended to have their booster with an mRNA vaccine (Pfizer/BioNTech or Moderna), provided this is possible from a medical point of view.

The cantons are responsible for carrying out the booster vaccinations. If a booster vaccination is recommended for you, you can register for an appointment. Visit the website or call the Infoline for your canton to find out where you should register and where you can get vaccinated. Alternatively, you can ask your doctor or pharmacist.

Who covers the costs of the vaccination?

The costs of a COVID-19 vaccination are covered by compulsory health insurance. The costs that are not covered by health insurance are borne by the federal government and the cantons. This applies to both initial immunisation and the booster.

Do you have compulsory health insurance in Switzerland? Then the vaccination (initial immunisation and booster) free of charge for you. You don’t have to pay any deductible or copayment.

Do you not have compulsory health insurance in Switzerland? Then the COVID-19 vaccination (initial
isimmunisation and booster) also free of charge for you in the following cases:

  • Your permanent or habitual place of residence is in Switzerland. (This applies, for example, to people who work for a diplomatic or consular representation or an international organisation, including members of their families, and to employees on secondment, students and retired people.)
  • You are a cross-border commuter. Please ask your employer for more information about how vaccinations are organised.
  • You are a Swiss citizen living abroad or an immediate family member (partner, child, parent, parent-in-law) living in the same household as the Swiss citizen living abroad.

For these groups the costs of the COVID-19 vaccination in Switzerland will be covered by the federal government.

The costs will not be covered if you are not in one of the groups listed above. This is the case, for example, for travellers from other countries such as tourists or business travellers. You should have the COVID-19 vaccination at your place of residence.

You will find more detailed information on the funding of the COVID-19 vaccination on the page for health professionals (in German, French and Italian).

How is the vaccination documented?

Every COVID-19 vaccination is documented. Below you’ll find information on the various possibilities for documenting the vaccination.

Proof of vaccination/vaccination record

At most vaccination locations, you will receive printed proof of vaccination from the healthcare professional after you have been vaccinated. This proof of vaccination lists the date and location of the vaccination, as well as information on the vaccine administered (trade name, manufacturer and batch number). At some vaccination locations, you can get the COVID-19 vaccinations entered directly in your vaccination record.

The proof of vaccination is a medical certificate and not an official document.

COVID certificate

Information is available on the COVID certificate page.

When am I fully vaccinated?

You are deemed to be fully vaccinated in the following cases:

1. You have received two doses of the following vaccines:

  • Comirnaty® from Pfizer/BioNTech
  • Spikevax® from Moderna
  • Vaxzevria® from AstraZeneca and other licensed products
  • SARS-CoV-2 Vaccine from Sinopharm
  • CoronaVac from Sinovac

2. You have received one dose of the Janssen vaccine from Johnson & Johnson

3. You have had a confirmed coronavirus infection and have received one dose of a vaccine specified in point 1 at an interval of at least 4 weeks (regardless of the order).

4. You have received a combination of the following vaccines:

  • Comirnaty® from Pfizer/BioNTech and Spikevax® from Moderna
  • Vaxzevria® from AstraZeneca and Comirnaty® from Pfizer/BioNTech
  • Vaxzevria® from AstraZeneca and Spikevax® from Moderna

Note: No time needs to elapse after the last scheduled dose of vaccine before you are deemed to be fully vaccinated – even though, from a medical point of view, the expected immune protection develops after around 1 to 2 weeks. With the exception of the Janssen viral vector vaccine. With Janssen you are fully vaccinated 22 days after the injection.

For which vaccines does Switzerland have a contract?

How are vaccines procured, developed and authorised?

Swiss vaccine procurement

The federal government is still in discussions with various vaccine producers. It is pursuing several vaccine procurement avenues and is also working internationally to this end. The federal government is also keen to procure different types of vaccine if possible. The public should also be offered alternatives to mRNA vaccines. This is because on the one hand there are people who are allergic to the ingredients of mRNA vaccines and therefore cannot get vaccinated. On the other, there are people who would prefer a conventional type of vaccine over the innovative mRNA technology. The federal government is keen to offer these people an alternative so they can get protected against COVID-19 as soon as possible.

Agreements with vaccine producers

The federal government has signed agreements with five vaccine manufacturers. Once a vaccine is approved by Swissmedic, Switzerland receives the number of doses reserved under the terms of the agreement. The vaccine manufacturers deliver the reserved doses to Switzerland in stages over several months.

  • Novavax: 6 million doses of vaccine
  • Pfizer/BioNTech: 6 million doses of vaccine in 2021 / 7 million doses in 2022 / 7 million doses in 2023
  • AstraZeneca: 5.3 million doses of vaccine
  • Moderna: 13.5 million doses of vaccine in 2021 / 7 million doses in 2022
  • Janssen: 150,000 vaccine doses in October 2021

Switzerland gets additional access to vaccines because it is a member of the COVAX programme. Click on the link below for more information on the COVAX programme.

Development of a vaccine

The development and production of vaccines is a complex and costly task. The requirements placed on quality, effectiveness and, in particular, safety are high. That is why a vaccine has to undergo different development phases during production. A vaccine only moves to the next stage of further development once the existing phase produces good results.

Approval in Switzerland

Swissmedic is responsible for authorisation in Switzerland and decides whether a vaccine can be authorised. If Swissmedic is able to confirm the efficacy, safety and quality of the vaccine, it will grant market approval for Switzerland.

What is vaccination?

Vaccinations are the most effective protection against dangerous infectious diseases. They reduce the vaccinated individual’s risk of infection and falling ill. Furthermore, many vaccines also protect against transmission of pathogens to others, meaning that non-vaccinated members of the population are also protected indirectly.

Using a vaccine, the immune system is “acquainted” with the pathogen that gives rise to a disease without actually triggering the disease. This prepares the body’s own defence system should it be faced with an emergency situation. If a vaccinated person subsequently comes into contact with the pathogen, the immune system can quickly recognise it and render it harmless.

Further information on this topic can be found on the page Vaccinations and prevention.

Swissmedic has a video explaining the way a vaccination works.

Frequently Asked Questions (FAQs)

Additional information

  • On the Infovac website (available in German, French and Italian) you will find information on the different vaccine types.
  • In the Swissmedic article “Prevention rather than cure” (in German) you will find information on the authorisation of vaccines in Switzerland.
  • On the Swissmedic website you will find a document describing the recommendations for the treatment of patients in clinical trials during the development of a SARS-CoV-2 vaccine.
  • On the FCV website (available in German, French and Italian) you will find the catalogue of questions (analysis framework) used to decide whether a vaccine should be recommended.

Further information

Disease, symptoms, treatment

Information on Covid-19, the symptoms and the range of illness severity as well as the origin of the new coronavirus

Last modification 18.01.2022

Top of page


Federal Office of Public Health FOPH
COVID-19 vaccination Infoline
Tel. +41 800 88 66 44

Print contact